In a filing, Surgery Partners Inc revealed its Chief Admin & Dev Officer Baldock Jennifer unloaded Company’s shares for reported $14651.0 on Mar 14 ’25. In the deal valued at $23.94 per share,612 shares were sold. As a result of this transaction, Baldock Jennifer now holds 236,047 shares worth roughly $5.27 million.
Then, Burkhalter Danielle sold 74 shares, generating $1,760 in total proceeds. Upon selling the shares at $23.78, the Chief Human Resources Officer now owns 44,839 shares.
Before that, Webb William Trenton sold 138 shares. Surgery Partners Inc shares valued at $3,271 were divested by the American Group President at a price of $23.70 per share. As a result of the transaction, Webb William Trenton now holds 74,521 shares, worth roughly $1.66 million.
A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. UBS began covering SGRY with “Buy” recommendation on October 14, 2024. KeyBanc Capital Markets started covering the stock on October 11, 2024. It rated SGRY as “a Sector weight”.
Price Performance Review of SGRY
On Tuesday, Surgery Partners Inc [NASDAQ:SGRY] saw its stock fall -0.49% to $22.33. Over the last five days, the stock has gained 1.22%. Surgery Partners Inc shares have fallen nearly -27.38% since the year began. Nevertheless, the stocks have risen 5.48% over the past one year. While a 52-week high of $33.97 was reached on 02/14/25, a 52-week low of $18.87 was recorded on 06/20/25.
Levels Of Support And Resistance For SGRY Stock
The 24-hour chart illustrates a support level at 22.20, which if violated will result in even more drops to 22.07. On the upside, there is a resistance level at 22.53. A further resistance level may holdings at 22.73.
How much short interest is there in Surgery Partners Inc?
A steep rise in short interest was recorded in Surgery Partners Inc stocks on 2025-07-15, growing by 2.43 million shares to a total of 11.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 9.41 million shares. There was a rise of 20.53%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 28, 2024 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $31 price target.
